Pre-Clinical In Vitro Studies

Pre-Clinical In Vivo Studies

IND Filing

EBT-101 HIV multiplex Cas9 dual gRNA Therapeutic

2020

EBT-103 PML/JCV Cas9 triplet gRNA T-antigen Therapeutic

Q1 2022

EBT-104 HSV Cas9 dual gRNA Therapeutic

Q4 2022

EBT-107 HBV CasX or Y dual gRNA Therapeutic

Q3 2023

EBT-201 COVID-19 Treatment & Prevention: CasY, Cas9, Cas13a

In Development

988 Market Street
San Francisco, CA 94102
USA

1755 N. 13th Street #274
Philadelphia, PA 19122
USA

© 2020 Excision BioTherapeutics. All Rights Reserved.